Clearmind Medicine Inc
CMND
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.51M
Close$
$1.20
29.6% downside
Current Fair Value
29.6% downsideOvervalued by 29.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.51 Million |
|---|---|
| Enterprise Value | $-8,778,311.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-3.03 |
| Beta | -1.19 |
| Outstanding Shares | 301,964 |
Return
| Return on Equity | -83.42% |
|---|---|
| Return on Assets | -66.00% |
| Return on Invested Capital | -76.49% |
Valuation & Multiples
| P/E Ratio | -0.15 |
|---|---|
| PEG | -0.09 |
| Price to Sales | - |
| Price to Book Ratio | 0.05 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 0.99 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.01 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
June 15, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 1.49%▲ 1.27% |
|---|---|
| Total Invested | $46,214▲ 284.70% |
| Investors Holding | 4▲ 2.00% |
ESG Score
No data